C12Y 301/26003
Ribonuclease iii
Official title: Ribonuclease III (3.1.26.3)
C12Y301/26003 (Ribonuclease iii) appears on 20 US grants and 50 published applications in this corpus.
Search patents in C12Y- Granted patents
- 20
- Published applications
- 50
- Assignees
- 29
- Inventors
- 84
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 2 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 3 | 2 |
| 2013 | 1 | 5 |
| 2014 | 3 | 5 |
| 2015 | 0 | 3 |
| 2016 | 4 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 2 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 3 |
| 2023 | 1 | 1 |
| 2024 | 1 | 2 |
| 2025 | 0 | 4 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating cancer3 Mar 2026US 12,564,623 B2The University of Chicago
- Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect13 Aug 2024US 12,059,479 B2Cellscript, LLC
- Systems, methods and composition of using RNase III mutants to produce sRNA to control host pathogen infection31 Oct 2023US 11,800,872 B2Pebble Labs Inc.
- RNA affinity purification12 Jul 2022US 11,384,352 B2ModernaTX, Inc.
- Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect5 Oct 2021US 11,135,314 B2Cellscript, LLC
- Methods and compositions for treating cancer28 May 2026US 2026/0144854 A1The University of Chicago
- Guide polynucleotide multiplexing12 Mar 2026US 2026/0071228 A1Pioneer Hi-Bred International, Inc.
- Solanaceous plant resistant to virus of genus begomovirus causing tomato yellow leaf curl symptoms, solanaceous plant cell, and method for producing solanaceous plant16 Oct 2025US 2025/0320517 A1Kikkoman Corporation
- Methods for Suppression of Gene Silencing in Plants28 Aug 2025US 2025/0270583 A1BioDrive, Inc.
- Making and using in vitro synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect7 Aug 2025US 2025/0249128 A1Cellscript, LLC
Most cited
By later US patents
- RNA affinity purification45US 11,384,352 B2ModernaTX, Inc. · 2022
- Methods and compositions for RNA interference22US 8,202,846 B2Cold Spring Harbor Laboratory · 2012
- Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect15US 10,201,620 B2Cellscript, LLC · 2019
- Method of producing dicer12US 9,434,930 B2The Regents of the University of California · 2016
- Methods and compositions relating to gene silencing10US 7,700,758 B2New England Biolabs, Inc. · 2010